Genetic Testing in CYLD Cutaneous Syndrome: An Update

References

• Rajan N, Langtry JA, Ashworth A, et al. Tumor mapping in 2 large multigenerational families with CYLD mutations: implications for disease management and tumor induction. Arch Dermatol. 2009;145:1277–1284. doi:10.1001/archdermatol.2009.262
   Google Scholar
• Blake PW, Toro JR. Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling. Hum Mutat. 2009;30:1025–1036. doi:10.1002/humu.21024
   PubMed Web of Science ®Google Scholar
• Brown S, Worthy SA, Langtry JAA, et al. Tracking tumor kinetics in patients with germline CYLD mutations. J Am Acad Dermatol. 2018;79:949–951. doi:10.1016/j.jaad.2018.04.014
   Web of Science ®Google Scholar
• van Balkom ID, Hennekam RC. Dermal eccrine cylindromatosis. J Med Genet. 1994;31:321–324. doi:10.1136/jmg.31.4.321
   Web of Science ®Google Scholar
• Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68:820–823. doi:10.1073/pnas.68.4.820
   PubMed Web of Science ®Google Scholar
• Davies HR, Hodgson K, Schwalbe E, et al. Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome. Nat Commun. 2019;10:4717. doi:10.1038/s41467-019-12746-w
   Web of Science ®Google Scholar
• Evans CD. Turban tumour. Br J Dermatol. 1954;66:434–443. doi:10.1111/j.1365-2133.1954.tb12575.x
   Web of Science ®Google Scholar
• Bajwa DS, Nasr B, Carmichael AJ, et al. Milia: a useful clinical marker of CYLD mutation carrier status. Clin Exp Dermatol. 2018;43:193–195. doi:10.1111/ced.13296
   Web of Science ®Google Scholar
• Massoumi R, Podda M, Fassler R, et al. Cylindroma as tumor of hair follicle origin. J Invest Dermatol. 2006;126:1182–1184. doi:10.1038/sj.jid.5700218
   PubMed Web of Science ®Google Scholar
• Sellheyer K. Spiradenoma and cylindroma originate from the hair follicle bulge and not from the eccrine sweat gland: an immunohistochemical study with CD200 and other stem cell markers. J Cutan Pathol. 2015;42:90–101. doi:10.1111/cup.12406
   Web of Science ®Google Scholar
• Cotton DW, Braye SG. Dermal cylindromas originate from the eccrine sweat gland. Br J Dermatol. 1984;111:53–61. doi:10.1111/j.1365-2133.1984.tb04016.x
   Web of Science ®Google Scholar
• Bilroth T. Die cylindergeschwulst (cylindroma) in Untersuchungenuber die Entwicklung der Blutgefasse, nebstBeobachtungenaus der koniglichenchirugischenUniverstats-Klink zu Berlin. Berlin: Riemer Germany; 1856:1855–1869.
   Google Scholar
• Michal M, Lamovec J, Mukensnabl P, et al. Spiradenocylindromas of the skin: tumors with morphological features of spiradenoma and cylindroma in the same lesion: report of 12 cases. Pathol Int. 1999;49:419–425. doi:10.1046/j.1440-1827.1999.00890.x
   Web of Science ®Google Scholar
• Kazakov DV, Magro G, Kutzner H, et al. Spiradenoma and spiradenocylindroma with an adenomatous or atypical adenomatous component: a clinicopathological study of 6 cases. Am J Dermatopathol. 2008;30:436–441. doi:10.1097/DAD.0b013e3181812729
   Web of Science ®Google Scholar
• Rajan N, Burn J, Langtry J, et al. Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expression. J Pathol. 2011;224:309–321. doi:10.1002/path.2896
   Web of Science ®Google Scholar
• Rashid M, van der Horst M, Mentzel T, et al. ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma. Nat Commun. 2019;10:2213. doi:10.1038/s41467-019-09979-0
   Web of Science ®Google Scholar
• Freedman AM, Woods JE. Total scalp excision and auricular resurfacing for dermal cylindroma (turban tumor). Ann Plast Surg. 1989;22:50–57. doi:10.1097/00000637-198901000-00010
   Web of Science ®Google Scholar
• Langtry J, Rajan N. Pre-emptive intra-auricular electrosurgical resurfacing of cylindromas to prevent conductive deafness in CYLD cutaneous syndrome. Br J Dermatol. 2020;183:e188. doi:10.1111/bjd.19331
   Web of Science ®Google Scholar
• Chang YC, Colome-Grimmer M, Kelly E. Multiple trichoepitheliomas in the lines of Blaschko. Pediatr Dermatol. 2006;23:149–151. doi:10.1111/j.1525-1470.2006.00202.x
   Web of Science ®Google Scholar
• Furuichi M, Makino T, Yamakoshi T, et al. Blaschkoid distribution of cylindromas in a germline CYLD mutation carrier. Br J Dermatol. 2012;166:1376–1378. doi:10.1111/j.1365-2133.2012.10869.x
   Web of Science ®Google Scholar
• Blaschko A. Die Nevenverteilung in derhant in ihrer Beziehung zuden Ekrankungender Haut. In: Verhand Deust Dermatol Gessel. Breslan: VH Congress; 1901.
   Google Scholar
• Moss C, Larkins S, Stacey M, et al. Epidermal mosaicism and Blaschko’s lines. J Med Genet. 1993;30:752–755. doi:10.1136/jmg.30.9.752
   Web of Science ®Google Scholar
• Happle R. Segmental forms of autosomal dominant skin disorders: different types of severity reflect different states of zygosity. Am J Med Genet. 1996;66:241–242. doi:10.1002/(SICI)1096-8628(19961211)66:2<241::AID-AJMG24>3.0.CO;2-S
   Web of Science ®Google Scholar
• Arefi M, Wilson V, Muthiah S, et al. Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmission. J Am Acad Dermatol. 2019;81:1300–1307. doi:10.1016/j.jaad.2019.05.021
   Web of Science ®Google Scholar
• Gerretsen AL, van der Putte SC, Deenstra W, et al. Cutaneous cylindroma with malignant transformation. Cancer. 1993;72:1618–1623. doi:10.1002/1097-0142(19930901)72:5<1618::AID-CNCR2820720521>3.0.CO;2-5
   PubMed Web of Science ®Google Scholar
• Durani BK, Kurzen H, Jaeckel A, et al. Malignant transformation of multiple dermal cylindromas. Br J Dermatol. 2001;145:653–656. doi:10.1046/j.1365-2133.2001.04460.x
   Web of Science ®Google Scholar
• Serracino HS, Kleinschmidt-Demasters BK. Skull invaders: when surgical pathology and neuropathology worlds collide. J Neuropathol Exp Neurol. 2013;72:600–613. doi:10.1097/NEN.0b013e318299c40f
   Web of Science ®Google Scholar
• Gildea JH, Lillehei KO, Golitz LE, et al. Benign cylindroma causing transcalvarial invasion in a patient with familial cylindromatosis. Clin Neuropathol. 2007;26:125–130. doi:10.5414/NPP26125
   Web of Science ®Google Scholar
• Kazakov DV, Zelger B, Rutten A, et al. Morphologic diversity of malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma based on the study of 24 cases, sporadic or occurring in the setting of Brooke-Spiegler syndrome. Am J Surg Pathol. 2009;33:705–719. doi:10.1097/PAS.0b013e3181966762
   PubMed Web of Science ®Google Scholar
• Ma H, Feng S, Pei W, et al. Twelve years’ observation of multiple familial trichoepithelioma with squamous carcinoma. Indian J Dermatol. 2016;61:348. doi:10.4103/0019-5154.182464
   Web of Science ®Google Scholar
• Ganguly S, Jaykar KC, Banerjee PK, et al. Multiple familial trichoepitheliomas in association with squamous cell carcinoma. Indian Dermatol Online J. 2012;3:151–153. doi:10.4103/2229-5178.96726
   Google Scholar
• Dubois A, Mestre T, Oliphant T, et al. Squamous cell carcinoma and multiple familial trichoepitheliomas: a recurrent association. Acta Derm Venereol. 2018;98:910–911. doi:10.2340/00015555-2988
   Web of Science ®Google Scholar
• Schulz T, Proske S, Hartschuh W, et al. High-grade trichoblastic carcinoma arising in trichoblastoma: a rare adnexal neoplasm often showing metastatic spread. Am J Dermatopathol. 2005;27:9–16. doi:10.1097/01.dad.0000142240.93956.cb
   PubMed Web of Science ®Google Scholar
• Melly L, Lawton G, Rajan N. Basal cell carcinoma arising in association with trichoepithelioma in a case of Brooke-Spiegler syndrome with a novel genetic mutation in CYLD. J Cutan Pathol. 2012;39:977–978. doi:10.1111/j.1600-0560.2012.01952.x
   Web of Science ®Google Scholar
• Arruda AP, Cardoso-Dos-Santos AC, Mariath LM, et al. A large family with CYLD cutaneous syndrome: medical genetics at the community level. J Community Genet. 2020;11:279–284. doi:10.1007/s12687-019-00447-2
   Web of Science ®Google Scholar
• Jungehulsing M, Wagner M, Damm M. Turban tumour with involvement of the parotid gland. J Laryngol Otol. 1999;113:779–783. doi:10.1017/S0022215100145190
   PubMed Web of Science ®Google Scholar
• Zarbo RJ. Salivary gland neoplasia: a review for the practicing pathologist. Mod Pathol. 2002;15:298–323. doi:10.1038/modpathol.3880525
   Web of Science ®Google Scholar
• Hyman BA, Scheithauer BW, Weiland LH, et al. Membranous basal cell adenoma of the parotid gland. Malignant transformation in a patient with multiple dermal cylindromas. Arch Pathol Lab Med. 1988;112:209–211.
   Web of Science ®Google Scholar
• Kazakov DV. Brooke-Spiegler syndrome and phenotypic variants: an update. Head Neck Pathol. 2016;10:125–130. doi:10.1007/s12105-016-0705-x
   PubMed Web of Science ®Google Scholar
• Vernon HJ, Olsen EA, Vollmer RT. Autosomal dominant multiple cylindromas associated with solitary lung cylindroma. J Am Acad Dermatol. 1988;19:397–400. doi:10.1016/S0190-9622(88)70186-3
   Web of Science ®Google Scholar
• Brown SM, Arefi M, Stones R, et al. Inherited pulmonary cylindromas: extending the phenotype of CYLD mutation carriers. Br J Dermatol. 2018;179:662–668. doi:10.1111/bjd.16573
   Web of Science ®Google Scholar
• Bulau JE, Kreipe HH, Jessen E, et al. Pulmonary cylindromas in CYLD cutaneous syndrome: a rare differential diagnosis of pulmonary adenoid cystic carcinoma. Clin Lung Cancer. 2021. doi:10.1016/j.cllc.2021.03.016
   Web of Science ®Google Scholar
• Biggs PJ, Wooster R, Ford D, et al. Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene. Nat Genet. 1995;11:441–443. doi:10.1038/ng1295-441
   Web of Science ®Google Scholar
• Bignell GR, Warren W, Seal S, et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet. 2000;25:160–165. doi:10.1038/76006
   PubMed Web of Science ®Google Scholar
• Takahashi M, Rapley E, Biggs PJ, et al. Linkage and LOH studies in 19 cylindromatosis families show no evidence of genetic heterogeneity and refine the CYLD locus on chromosome 16q12-q13. Hum Genet. 2000;106:58–65. doi:10.1007/s004399900227
   Web of Science ®Google Scholar
• Zhang XJ, Liang YH, He PP, et al. Identification of the cylindromatosis tumor-suppressor gene responsible for multiple familial trichoepithelioma. J Invest Dermatol. 2004;122:658–664. doi:10.1111/j.0022-202X.2004.22321.x
   Web of Science ®Google Scholar
• van den Ouweland AM, Elfferich P, Lamping R, et al. Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis. Fam Cancer. 2011;10:127–132. doi:10.1007/s10689-010-9393-y
   Web of Science ®Google Scholar
• Kazakov DV, Thoma-Uszynski S, Vanecek T, et al. A case of Brooke-Spiegler syndrome with a novel germline deep intronic mutation in the CYLD gene leading to intronic exonization, diverse somatic mutations, and unusual histology. Am J Dermatopathol. 2009;31:664–673. doi:10.1097/DAD.0b013e3181a05dad
   Web of Science ®Google Scholar
• Vanecek T, Halbhuber Z, Kacerovska D, et al. Large germline deletions of the CYLD gene in patients with Brooke-Spiegler syndrome and multiple familial trichoepithelioma. Am J Dermatopathol. 2014;36:868–874. doi:10.1097/DAD.0000000000000068
   Web of Science ®Google Scholar
• Dobson-Stone C, Hallupp M, Shahheydari H, et al. CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis. Brain. 2020;143:783–799. doi:10.1093/brain/awaa039
   Web of Science ®Google Scholar
• Cunningham F, Amode MR, Barrell D, et al. Ensembl 2015. Nucleic Acids Res. 2015;43:D662–9. doi:10.1093/nar/gku1010
   PubMed Web of Science ®Google Scholar
• Kupka S, De Miguel D, Draber P, et al. SPATA2-mediated binding of CYLD to HOIP enables CYLD recruitment to signaling complexes. Cell Rep. 2016;16:2271–2280. doi:10.1016/j.celrep.2016.07.086
   PubMed Web of Science ®Google Scholar
• Elliott PR, Leske D, Hrdinka M, et al. SPATA2 links CYLD to LUBAC, activates CYLD, and controls LUBAC signaling. Mol Cell. 2016;63:990–1005. doi:10.1016/j.molcel.2016.08.001
   Web of Science ®Google Scholar
• Lork M, Verhelst K, Beyaert R. CYLD, A20 and OTULIN deubiquitinases in NF-kappaB signaling and cell death: so similar, yet so different. Cell Death Differ. 2017;24:1172–1183. doi:10.1038/cdd.2017.46
   PubMed Web of Science ®Google Scholar
• Hellerbrand C, Massoumi R. Cylindromatosis–a protective molecule against liver diseases. Med Res Rev. 2016;36:342–359. doi:10.1002/med.21381
   PubMed Web of Science ®Google Scholar
• Masoumi KC, Shaw-Hallgren G, Massoumi R. Tumor suppressor function of CYLD in nonmelanoma skin cancer. J Skin Cancer. 2011;2011:614097. doi:10.1155/2011/614097
   Google Scholar
• Massoumi R. Ubiquitin chain cleavage: CYLD at work. Trends Biochem Sci. 2010;35:392–399. doi:10.1016/j.tibs.2010.02.007
   PubMed Web of Science ®Google Scholar
• Kloepper JE, Ernst N, Krieger K, et al. NF-κB activity is required for anagen maintenance in human hair follicles in vitro. J Invest Dermatol. 2014;134:2036–2038. doi:10.1038/jid.2014.82
   PubMed Web of Science ®Google Scholar
• Tauriello DV, Haegebarth A, Kuper I, et al. Loss of the tumor suppressor CYLD enhances Wnt/β-catenin signaling through K63-linked ubiquitination of Dvl. Mol Cell. 2010;37:607–619. doi:10.1016/j.molcel.2010.01.035
   PubMed Web of Science ®Google Scholar
• Rajan N, Elliott RJ, Smith A, et al. The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate notch signalling. Oncotarget. 2014;5:12126–12140. doi:10.18632/oncotarget.2573
   Google Scholar
• Lim JH, Jono H, Komatsu K, et al. CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt. Nat Commun. 2012;3:771. doi:10.1038/ncomms1776
   PubMed Web of Science ®Google Scholar
• Rajan N, Elliott R, Clewes O, et al. Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours. Oncogene. 2011;30:4243–4260. doi:10.1038/onc.2011.133
   PubMed Web of Science ®Google Scholar
• Nagy N, Farkas K, Kemeny L, et al. Phenotype-genotype correlations for clinical variants caused by CYLD mutations. Eur J Med Genet. 2015;58:271–278. doi:10.1016/j.ejmg.2015.02.010
   Web of Science ®Google Scholar
• Dubois A, Wilson V, Bourn D, et al. CYLD GeneticTesting for Brooke-Spiegler syndrome, familial cylindromatosis and multiple familial trichoepitheliomas. PLoS Curr. 2015;7. doi:10.1371/currents.eogt.45c4e63dd43d62e12228cc5264d6a0db
   Google Scholar
• Hunstig F, Schulz S, Nieten I, et al. A case of Brooke-Spiegler syndrome with a novel mutation in the CYLD gene in a patient with aggressive non-Hodgkin’s lymphoma. J Cancer Res Clin Oncol. 2016;142:845–848. doi:10.1007/s00432-015-2079-y
   Web of Science ®Google Scholar
• Tantcheva-Poor I, Vanecek T, Lurati MC, et al. Report of three novel germline CYLD mutations in unrelated patients with Brooke-Spiegler syndrome, including classic phenotype, multiple familial trichoepitheliomas and malignant transformation. Dermatology. 2016;232:30–37. doi:10.1159/000437303
   Web of Science ®Google Scholar
• Shiver M, Hughes M, Naylor M, et al. A novel CYLD gene mutation and multiple basal cell carcinomas in a patient with Brooke-Spiegler syndrome. Clin Exp Dermatol. 2016;41:98–100. doi:10.1111/ced.12669
   Web of Science ®Google Scholar
• Pinho AC, Gouveia MJ, Gameiro AR, et al. Brooke-Spiegler Syndrome - an underrecognized cause of multiple familial scalp tumors: report of a new germline mutation. J Dermatol Case Rep. 2015;9:67–70. doi:10.3315/jdcr.2015.1208
   Google Scholar
• Malzone MG, Campanile AC, Losito NS, et al. Brooke-Spiegler syndrome presenting multiple concurrent cutaneous and parotid gland neoplasms: cytologic findings on fine-needle sample and description of a novel mutation of the CYLD gene. Diagn Cytopathol. 2015;43:654–658. doi:10.1002/dc.23275
   Web of Science ®Google Scholar
• Gao J, Huo L, Sun X, et al. The tumor suppressor CYLD regulates microtubule dynamics and plays a role in cell migration. J Biol Chem. 2008;283:8802–8809. doi:10.1074/jbc.M708470200
   Web of Science ®Google Scholar
• Sima R, Vanecek T, Kacerovska D, et al. Brooke-Spiegler syndrome: report of 10 patients from 8 families with novel germline mutations: evidence of diverse somatic mutations in the same patient regardless of tumor type. Diagn Mol Pathol. 2010;19:83–91. doi:10.1097/PDM.0b013e3181ba2d96
   PubMedGoogle Scholar
• Cakmak Genc G, Dursun A, Nagy N, et al. Brooke-Spiegler syndrome: two patients from a Turkish family with multiple familial trichoepithelioma. Am J Dermatopathol. 2019;41:778–780. doi:10.1097/DAD.0000000000001265
   Web of Science ®Google Scholar
• Bowen S, Gill M, Lee DA, et al. Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation. J Invest Dermatol. 2005;124:919–920. doi:10.1111/j.0022-202X.2005.23688.x
   Web of Science ®Google Scholar
• Saggar S, Chernoff KA, Lodha S, et al. CYLD mutations in familial skin appendage tumours. J Med Genet. 2008;45:298–302. doi:10.1136/jmg.2007.056127
   Web of Science ®Google Scholar
• Wu JW, Xiao SX, Huo J, et al. A novel frameshift mutation in the cylindromatosis (CYLD) gene in a Chinese family with multiple familial trichoepithelioma. Arch Dermatol Res. 2014;306:857–860. doi:10.1007/s00403-014-1499-x
   Web of Science ®Google Scholar
• Grossmann P, Vanecek T, Steiner P, et al. Novel and recurrent germline and somatic mutations in a cohort of 67 patients from 48 families with Brooke-Spiegler syndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens. Am J Dermatopathol. 2013;35:34–44.
   Web of Science ®Google Scholar
• Hongli J, Lifeng Z, Zhenzhen F, et al. Detection of grass carp reovirus (GCRV) with monoclonal antibodies. Arch Virol. 2014;159:649–655. doi:10.1007/s00705-013-1864-7
   PubMed Web of Science ®Google Scholar
• Reuven B, Margarita I, Dov H, et al. Multiple trichoepitheliomas associated with a novel heterozygous mutation in the CYLD gene as an adjunct to the histopathological diagnosis. Am J Dermatopathol. 2013;35:445–447. doi:10.1097/DAD.0b013e31827132af
   Web of Science ®Google Scholar
• Hester CC, Moscato EE, Kazakov DV, et al. A new Cylindromatosis (CYLD) gene mutation in a case of Brooke-Spiegler syndrome masquerading as basal cell carcinoma of the eyelids. Ophthalmic Plast Reconstr Surg. 2013;29:e10–1. doi:10.1097/IOP.0b013e3182565c41
   Web of Science ®Google Scholar
• Ying ZX, Ma HQ, Liu Y, et al. A novel mutation of CYLD in a Chinese family with multiple familial trichoepithelioma. J Eur Acad Dermatol Venereol. 2012;26:1420–1423. doi:10.1111/j.1468-3083.2011.04309.x
   Web of Science ®Google Scholar
• Chen M, Liu H, Fu X, et al. Mutation analysis of the CYLD gene in two Chinese families with multiple familial Trichoepithelioma. Australas J Dermatol. 2011;52:146–147. doi:10.1111/j.1440-0960.2011.00763.x
   Web of Science ®Google Scholar
• Kazakov DV, Vanecek T, Zelger B, et al. Multiple (familial) trichoepitheliomas: a clinicopathological and molecular biological study, including CYLD and PTCH gene analysis, of a series of 16 patients. Am J Dermatopathol. 2011;33:251–265. doi:10.1097/DAD.0b013e3181f7d373
   PubMed Web of Science ®Google Scholar
• Liang YH, Sun CS, Ye XY, et al. Novel substitution and frameshift mutations of CYLD in two Chinese families with multiple familial trichoepithelioma. Br J Dermatol. 2008;158:1156–1158. doi:10.1111/j.1365-2133.2008.08491.x
   PubMed Web of Science ®Google Scholar
• Heinritz W, Grunewald S, Strenge S, et al. A case of Brooke-Spiegler syndrome with a new mutation in the CYLD gene. Br J Dermatol. 2006;154:992–994. doi:10.1111/j.1365-2133.2006.07142.x
   Web of Science ®Google Scholar
• Zheng G, Hu L, Huang W, et al. CYLD mutation causes multiple familial trichoepithelioma in three Chinese families. Hum Mutat. 2004;23:400. doi:10.1002/humu.9231
   Web of Science ®Google Scholar
• Salhi A, Bornholdt D, Oeffner F, et al. Multiple familial trichoepithelioma caused by mutations in the cylindromatosis tumor suppressor gene. Cancer Res. 2004;64:5113–5117. doi:10.1158/0008-5472.CAN-04-0307
   Web of Science ®Google Scholar
• Poblete Gutierrez P, Eggermann T, Holler D, et al. Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages. J Invest Dermatol. 2002;119:527–531. doi:10.1046/j.1523-1747.2002.01839.x
   Web of Science ®Google Scholar
• Almeida S, Maillard C, Itin P, et al. Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity. J Invest Dermatol. 2008;128:587–593. doi:10.1038/sj.jid.5701045
   Web of Science ®Google Scholar
• Oranje AP, Halley D, den Hollander JC, et al. Multiple familial trichoepithelioma and familial cylindroma: one cause! J Eur Acad Dermatol Venereol. 2008;22:1395–1396. doi:10.1111/j.1468-3083.2008.02648.x
   Web of Science ®Google Scholar
• Young AL, Kellermayer R, Szigeti R, et al. CYLD mutations underlie Brooke-Spiegler, familial cylindromatosis, and multiple familial trichoepithelioma syndromes. Clin Genet. 2006;70:246–249. doi:10.1111/j.1399-0004.2006.00667.x
   PubMed Web of Science ®Google Scholar
• Oiso N, Mizuno N, Fukai K, et al. Mild phenotype of familial cylindromatosis associated with an R758X nonsense mutation in the CYLD tumour suppressor gene. Br J Dermatol. 2004;151:1084–1086. doi:10.1111/j.1365-2133.2004.06231.x
   Web of Science ®Google Scholar
• Zhang G, Huang Y, Yan K, et al. Diverse phenotype of Brooke-Spiegler syndrome associated with a nonsense mutation in the CYLD tumor suppressor gene. Exp Dermatol. 2006;15:966–970. doi:10.1111/j.1600-0625.2006.00501.x
   Web of Science ®Google Scholar
• Farkas K, Deak BK, Sanchez LC, et al. The CYLD p.R758X worldwide recurrent nonsense mutation detected in patients with multiple familial trichoepithelioma type 1, Brooke-Spiegler syndrome and familial cylindromatosis represents a mutational hotspot in the gene. BMC Genet. 2016;17:36. doi:10.1186/s12863-016-0346-9
   Web of Science ®Google Scholar
• Amaro C, Freitas I, Lamarao P, et al. Multiple trichoepitheliomas–a novel mutation in the CYLD gene. J Eur Acad Dermatol Venereol. 2010;24:844–846. doi:10.1111/j.1468-3083.2009.03497.x
   Web of Science ®Google Scholar
• Espana A, Garcia-Amigot F, Aguado L, et al. A novel missense mutation in the CYLD gene in a Spanish family with multiple familial trichoepithelioma. Arch Dermatol. 2007;143:1209–1210. doi:10.1001/archderm.143.9.1209
   Google Scholar
• Zuo YG, Xu Y, Wang B, et al. A novel mutation of CYLD in a Chinese family with multiple familial trichoepithelioma and no CYLD protein expression in the tumour tissue. Br J Dermatol. 2007;157:818–821. doi:10.1111/j.1365-2133.2007.08081.x
   Web of Science ®Google Scholar
• Ly H, Black MM, Robson A. Case of the Brooke-Spiegler syndrome. Australas J Dermatol. 2004;45:220–222. doi:10.1111/j.1440-0960.2004.00101.x
   Google Scholar
• Wang FX, Yang LJ, Li M, et al. A novel missense mutation of CYLD gene in a Chinese family with multiple familial trichoepithelioma. Arch Dermatol Res. 2010;302:67–70. doi:10.1007/s00403-009-1003-1
   Web of Science ®Google Scholar
• Nagy N, Farkas K, Kinyo A, et al. A novel missense mutation of the CYLD gene identified in a Hungarian family with Brooke-Spiegler syndrome. Exp Dermatol. 2012;21:967–969. doi:10.1111/exd.12040
   Web of Science ®Google Scholar
• Huang TM, Chao SC, Lee JY. A novel splicing mutation of the CYLD gene in a Taiwanese family with multiple familial trichoepithelioma. Clin Exp Dermatol. 2009;34:77–80. doi:10.1111/j.1365-2230.2008.02870.x
   Web of Science ®Google Scholar
• Nasti S, Pastorino L, Bruno W, et al. Five novel germline function-impairing mutations of CYLD in Italian patients with multiple cylindromas. Clin Genet. 2009;76:481–485. doi:10.1111/j.1399-0004.2009.01259.x
   Web of Science ®Google Scholar
• Kazakov DV, Schaller J, Vanecek T, et al. Brooke-Spiegler syndrome: report of a case with a novel mutation in the CYLD gene and different types of somatic mutations in benign and malignant tumors. J Cutan Pathol. 2010;37:886–890. doi:10.1111/j.1600-0560.2010.01511.x
   Web of Science ®Google Scholar
• Schmidt A, Schmitz R, Giefing M, et al. Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma. Genes Chromosomes Cancer. 2010;49:803–809.
   PubMed Web of Science ®Google Scholar
• Kacerovska D, Szep Z, Kollarikova L, et al. A novel germline mutation in the CYLD gene in a Slovak patient with Brooke-Spiegler syndrome. Cesk Patol. 2013;49:89–92.
   Google Scholar
• Firth HV, Richards SM, Bevan AP, et al. DECIPHER: database of chromosomal imbalance and phenotype in humans using ensembl resources. Am J Hum Genet. 2009;84:524–533. doi:10.1016/j.ajhg.2009.03.010
   PubMed Web of Science ®Google Scholar
• Nagy N, Rajan N, Farkas K, et al. A mutational hotspot in CYLD causing cylindromas: a comparison of phenotypes arising in different genetic backgrounds. Acta Derm Venereol. 2013;93:743–745. doi:10.2340/00015555-1590
   Web of Science ®Google Scholar
• Hu G, Onder M, Gill M, et al. A novel missense mutation in CYLD in a family with Brooke-Spiegler syndrome. J Invest Dermatol. 2003;121:732–734. doi:10.1046/j.1523-1747.2003.12514.x
   Web of Science ®Google Scholar
• Pap EM, Farkas K, Szell M, et al. Identification of putative phenotype-modifying genetic factors associated with phenotypic diversity in Brooke-Spiegler syndrome. Exp Dermatol. 2020;29:1017–1020. doi:10.1111/exd.14161
   Web of Science ®Google Scholar
• Danis J, Kelemen E, Rajan N, et al. TRAF3 and NBR1 both influence the effect of the disease-causing CYLD(Arg936X) mutation on NF-κB activity. Exp Dermatol. 2021. doi:10.1111/exd.14365
   Web of Science ®Google Scholar
• Baden HP. Cylindromatosis simulating neurofibromatosis. N Engl J Med. 1962;267:296–297. doi:10.1056/NEJM196208092670608
   Web of Science ®Google Scholar
• Huang Y, Cai C, Ren L, et al. Marie Unna hereditary hypotrichosis accompanied by multiple familial trichoepithelioma in a Chinese family. J Dermatol. 2019;46:413–417. doi:10.1111/1346-8138.14811
   Web of Science ®Google Scholar
• Dubois A, Rajan N. CYLD cutaneous syndrome. In: Adam MP, Ardinger HH, Pagon RA, editors. GeneReviews((R)). Seattle: University of Washington, Seattle Copyright 1993–2020; 1993.
   Google Scholar
• Saunders H, Tucker P, Saurine T, et al. Pedigree of multiple benign adnexal tumours of Brooke-Spiegler type. Australas J Dermatol. 2003;44:144–148. doi:10.1046/j.1440-0960.2003.00663.x
   Google Scholar
• Rajan N, Trainer AH, Burn J, et al. Familial cylindromatosis and Brooke-Spiegler syndrome: a review of current therapeutic approaches and the surgical challenges posed by two affected families. Dermatol Surg. 2009;35:845–852. doi:10.1111/j.1524-4725.2009.01142.x
   Web of Science ®Google Scholar
• Danilenko M, Stamp E, Stocken DD, et al. Targeting tropomyosin receptor kinase in cutaneous CYLD defective tumors with pegcantratinib: the TRAC randomized clinical trial. JAMA Dermatol. 2018;154:913–921. doi:10.1001/jamadermatol.2018.1610
   PubMed Web of Science ®Google Scholar
• Dubois A, Hodgson K, Rajan N. Understanding inherited cylindromas: clinical implications of gene discovery. Dermatol Clin. 2017;35(1):61–71. doi:10.1016/j.det.2016.08.002
   Web of Science ®Google Scholar